Report

Update: Robust H2, prospects look good

Allocate’s full year trading update confirms that revenues were in line with expectations, while EBITDA and cash generation were ahead, with strong uptake of Allocate cloud boosting both cash generation and recurring revenues. With HealthRoster’s market position in the NHS looking rock-solid and SafeCare offering a promising source of incremental revenue streams, prospects for 2015 look good. We do not believe these prospects are reflected in the company’s rating of 14.3x FY15 P/E ratio.
Underlying
Allstate Corporation

Allstate is a holding company. Through its subsidiaries, the company is engaged in the property and casualty insurance business. The company's segments include: Allstate Protection, which provides private passenger auto, homeowners, other personal lines and commercial insurance; Service Businesses, which includes SquareTrade that provides consumer protection plans and related technical support; Allstate Life, which provides interest-sensitive and variable life insurance products, as well as distributes non-proprietary retirement products; and Allstate Benefits, which provides voluntary benefits products, including life, accident, critical illness, and other health insurance products.

Provider
Edison Investment Research
Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

.

Other Reports on these Companies
Other Reports from Edison Investment Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch